CME Group Inc (NASDAQ:CME) announced a quarterly dividend on Wednesday, November 6th, RTT News reports. Investors of record on Tuesday, December 10th will be given a dividend of 0.75 per share by the financial services provider on Friday, December 27th. This represents a $3.00 annualized dividend and a dividend yield of 1.51%.
NASDAQ CME opened at $199.00 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.04 and a debt-to-equity ratio of 0.14. CME Group has a twelve month low of $161.05 and a twelve month high of $224.91. The company has a market cap of $70.53 billion, a price-to-earnings ratio of 29.18, a price-to-earnings-growth ratio of 3.86 and a beta of 0.18. The business’s fifty day moving average is $208.72 and its 200 day moving average is $201.48.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.15. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The company had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the business posted $1.45 EPS. CME Group’s revenue for the quarter was up 41.3% on a year-over-year basis. On average, research analysts anticipate that CME Group will post 6.91 earnings per share for the current fiscal year.
In other news, COO Julie Holzrichter sold 3,436 shares of CME Group stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $216.07, for a total value of $742,416.52. Following the completion of the transaction, the chief operating officer now directly owns 38,704 shares of the company’s stock, valued at approximately $8,362,773.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Daniel R. Glickman sold 500 shares of CME Group stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total value of $108,005.00. Following the completion of the transaction, the director now directly owns 14,593 shares of the company’s stock, valued at $3,152,233.93. The disclosure for this sale can be found here. Insiders have sold a total of 13,636 shares of company stock worth $3,001,008 over the last ninety days. Company insiders own 1.20% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: 52-Week High/Low
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.